Ligand Pharmaceutical Inc (LGND) Com Stk Class 'B' USD0.001

Sell:$173.76Buy:$244.22Price decreased$4.69 (2.23%)

NASDAQ:Price decreased2.01%
Market closed |
Prices delayed by at least 15 minutes
Sell:$173.76
Buy:$244.22
Change:Price decreased$4.69 (2.23%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$173.76
Buy:$244.22
Change:Price decreased$4.69 (2.23%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 March 2026
Octavio EspinozaCFO
Sell
Regular sell transaction (market)
3,057$225.00$687,825.0021,010
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
100$197.70$19,769.5441,769
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
100$199.01$19,900.5041,669
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
207$199.96$41,390.8941,462
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
93$200.62$18,657.8941,369
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
300$201.70$60,510.0041,069
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
200$204.17$40,834.0040,869
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
460$205.18$94,381.8840,409
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
340$206.37$70,164.7840,069
4 March 2026
Andrew Thomas ReardonChief Legal/Compliance Officer
Sell
Option/Award related
612$207.01$126,689.4539,457

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 February 2026
Todd C DavisCEO
Sell
Tax related
15,600$183.83$2,867,748.00197,985
14 February 2026
Todd C DavisCEO
Sell
Tax related
8,178$183.83$1,503,361.74173,941
14 February 2026
Octavio EspinozaCFO
Sell
Tax related
4,483$183.83$824,109.8936,531
23 September 2025
Jason M. AryehIndependent Director
Sell
Regular sell transaction (market)
4,628$170.96$791,222.7870,243
15 February 2026
Todd C DavisCEO
Sell
Tax related
4,255$183.83$782,196.65191,691

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.